EHEric D. Hoffer

Eric D. Hoffer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eric D. Hoffer has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Aminoglycoside conformation and ring substituents dictate evasion from bacterial resistance mechanisms

    by Debayan Dey, Eric D. Hoffer, Dillion Francis, Christine M. Dunham, Graeme L. Conn

    Ribosomal RNA (rRNA) methylation by aminoglycoside‐resistance methyltransferases is presumed to reduce antibiotic activity by sterically occluding part of the drug binding site in helix 44 of 16S rRNA. However, for 4,6‐disubstituted deoxystreptamine (4,6‐DOS) aminoglycosides, the m 1 A1408 aminoglycoside resistance modification results in a wide range of bacterial resistance phenotypes with structurally similar drugs, from complete resistance to highly susceptible. Thus, for currently undefined reasons, some 4,6‐DOS aminoglycosides appear to be able to “evade” the effects of rRNA methylation at A1408. In contrast for the m 7 G1405 aminoglycoside resistance modification, all 4,6‐DOS aminoglycosides are rendered inactive. Why these same drugs are unable to evade this methylation is also currently not mechanistically understood. We will describe the development of a framework for understanding methylated rRNA‐antibiotic interactions through the evaluation of energetics of drug‐methylated rRNA complexes for a collection of 4,6‐DOS aminoglycosides. With computational calculations using Monte Carlo simulations and free energy maps of aminoglycosides, we probed the flexibility around each ring’s dihedral angles (ϕ/ψ) in rRNA bound poses and the contributions of Ring I substituents to drug binding. These analyses revealed three key molecular features that may contribute to evasion of m 1 A1408 modification: 1) The polarity of atoms of the Ring I 6’ substituent; 2) the number of Ring I substituents; and 3) the presence of a L‐hydroxyaminobuteroyl amide (HABA) group on the 2‐DOS core ring. These studies lay a foundation for understanding aminoglycoside‐methylated rRNA interactions at the molecular level and could, for example, directly facilitate design of new aminoglycoside derivatives that retain activity against pathogens harboring aminoglycoside‐resistance rRNA methyltransferases. Support or Funding Information: This work was supported by National Institutes of Health grants R01‐AI088025 (to GLC) and Cystic Fibrosis Foundation postdoctoral fellowship DEY18F0 (to DD).

  • Role of RNA Modifications in tRNA Structural Stability and Accurate Protein Synthesis

    by Christine Dunham, Eric D. Hoffer, Ha An Nguyen, Sunita Subramanian, Samuel Hong, Tatsuya Maehigashi

  • Open Access

    RNA‐mediated Mechanisms of Translation Control

    by Christine M. Dunham, Eric D. Hoffer, Ha An Nguyen, Sunita Subramanian, Samuel Hong, Tatsuya Maehigashi

    Gene expression relies on the interplay of dozens of proteins and large nucleic acid molecules that assemble into complex macromolecular machines such as the ribosome. These machines are regulated by posttranscriptional and posttranslational modifications. Numerous tRNA modifications, for example, are known to influence the fidelity of mRNA decoding by the ribosome. In the absence of this translational fidelity, nonsense protein products are expressed or premature termination occurs resulting in toxic protein products that overwhelm the cellular proteolysis machinery resulting in cell death. Posttranscriptional modifications of tRNAs have been known for decades but most studies have focused on how anticodon modifications expand the genetic code by allowing non Watson‐Crick base‐pairing at the third position of the codon‐anticodon interaction on the ribosome. However, most tRNAs are also extensively modified outside their anticodon stem‐loop. These modifications affect other aspects of translational fidelity such as the ability of the ribosome to maintain the three‐nucleotide codon of the mRNA as it moves through the ribosome. The absolute requirement for precise correlation between the mRNA frame and the correct protein sequence to be expressed underlies an fundamental question in molecular biology: what regulates the mRNA reading frame? To address this question, we study two examples of defined biological systems that subvert the three‐nucleotide mRNA reading frame resulting in high levels of programmed frameshifting. Our biochemical and structural results reveal that tRNA distortion and conformational changes of the small ribosomal subunit are induced by frameshift‐prone tRNAs and highly structured mRNAs. These programmed gene expression events cause changes in the dynamic motions of the ribosome required for productive translation. This dysregulation causes the ribosome to lose its grip on the mRNA, allowing the tRNA to shift into a new reading frame. Together these studies reveal how the ribosome can be programmed for to encode for alternative mRNA frames and in addition suggest how dysregulation of the mRNA frame may occur by the disruption of key interactions between tRNAs, mRNA, and translation factors with the ribosome. This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

  • Open Access

    Uniformity of Peptide Release Is Maintained by Methylation of Release Factors

    by William E. Pierson, Eric D. Hoffer, Hannah E. Keedy, Carrie L. Simms, Christine M. Dunham, Hani S. Zaher


  • Open Access

    Growth-regulating Mycobacterium tuberculosis VapC-mt4 toxin is an isoacceptor-specific tRNase

    by Jonathan W. Cruz, Jared D. Sharp, Eric D. Hoffer, Tatsuya Maehigashi, Irina O. Vvedenskaya, Arvind Konkimalla, Robert N. Husson, Bryce E. Nickels, Christine M. Dunham, Nancy A. Woychik

    Toxin–antitoxin (TA) systems are implicated in the downregulation of bacterial cell growth associated with stress survival and latent tuberculosis infection, yet the activities and intracellular targets of these TA toxins are largely uncharacterized. Here, we use a specialized RNA-seq approach to identify targets of a Mycobacterium tuberculosis VapC TA toxin, VapC-mt4 (also known as VapC4), which have eluded detection using conventional approaches. Distinct from the one other characterized VapC toxin in M. tuberculosis that cuts 23S rRNA at the sarcin–ricin loop, VapC-mt4 selectively targets three of the 45 M. tuberculosis tRNAs (tRNAAla2, tRNASer26 and tRNASer24) for cleavage at, or adjacent to, their anticodons, resulting in the generation of tRNA halves. While tRNA cleavage is sometimes enlisted as a bacterial host defense mechanism, VapC-mt4 instead alters specific tRNAs to inhibit translation and modulate growth. This stress-linked activity of VapC-mt4 mirrors basic features of eukaryotic tRNases that also generate tRNA halves and inhibit translation in response to stress.